Murgo A J
W V Med J. 1989 Jun;85(6):233-8.
A better understanding of cellular immunology and advances in recombinant DNA technology have led to a new dimension in the immunological treatment of cancer in which the potential for success is greatly increased. The number of biological agents with the ability to enhance the host's anti-tumor defense mechanisms has markedly increased during the last decade. The development of clinical trials with these biological response modifiers is an area of intense research. As a result of these investigations, a variety of malignancies now can be treated successfully by immunological approaches.
对细胞免疫学的更深入理解以及重组DNA技术的进步，为癌症免疫治疗带来了新的维度，大大提高了成功的可能性。在过去十年中，具有增强宿主抗肿瘤防御机制能力的生物制剂数量显著增加。使用这些生物反应调节剂进行临床试验的开发是一个深入研究的领域。这些研究的结果是，现在多种恶性肿瘤可以通过免疫方法成功治疗。
